Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001927648-25-000007
Filing Date
2025-09-23
Accepted
2025-09-23 19:53:59
Documents
3
Period of Report
2025-09-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1758671635.html 3  
1 FORM 3 wk-form3_1758671635.xml 3 1651
2 EX-24 burkhartpoa_092225.htm EX-24 620
3 burkhartpoa_092225001.jpg GRAPHIC 207537
  Complete submission text file 0001927648-25-000007.txt   289726
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901
Business Address
Burkhart Erin (Reporting) CIK: 0001927648 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19731 | Film No.: 251334957